Deubiquitination of NF-κB by ubiquitin-specific protease-7 promotes transcription

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 2, 2013, Pages 618-623

  Colleran, Amy ^a   Collins, Patricia E ^a   O'Carroll, Christine ^a,b   Ahmed, Abrar ^a   Mao, Xicheng ^c   McManus, Bettina ^a   Kiely, Patrick A ^d   Burstein, Ezra ^c   Carmody, Ruaidhrí J ^e  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d UNIVERSITY OF LIMERICK   (Ireland)

^e UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR; UBIQUITIN; UBIQUITIN SPECIFIC PROTEASE 7; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DEUBIQUITINATION; EMBRYO; ENZYME ACTIVITY; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; UBIQUITINATION;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; GENE EXPRESSION REGULATION; HEK293 CELLS; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NF-KAPPA B; NIH 3T3 CELLS; PEPTIDES; REAL-TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA; UBIQUITIN THIOLESTERASE; UBIQUITINATION;

EID: 84872202679     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1208446110     Document Type: Article

References (34)

1. Carmody RJ, Chen YH (2007) Nuclear factor-kappaB: Activation and regulation during toll-like receptor signaling. Cell Mol Immunol 4(1):31-41.
2. Hayden MS, Ghosh S (2008) Shared principles in NF-kappaB signaling. Cell 132(3):344-362.
3. Ghosh S, Hayden MS (2008) New regulators of NF-kappaB in inflammation. Nat Rev Immunol 8(11):837-848.
4. Wan F, Lenardo MJ (2010) The nuclear signaling of NF-kappaB: Current knowledge, new insights, and future perspectives. Cell Res 20(1):24-33.
5. Mao X, et al. (2009) GCN5 is a required cofactor for a ubiquitin ligase that targets NF-kappaB/RelA. Genes Dev 23(7):849-861.
6. Ryo A, et al. (2003) Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. Mol Cell 12(6):1413-1426.
7. Tanaka T, Grusby MJ, Kaisho T (2007) PDLIM2-mediated termination of transcription factor NF-kappaB activation by intranuclear sequestration and degradation of the p65 subunit. Nat Immunol 8(6):584-591.
8. Maine GN, Mao X, Komarck CM, Burstein E (2007) COMMD1 promotes the ubiquitination of NF-kappaB subunits through a cullin-containing ubiquitin ligase. EMBO J 26(2):436-447.
9. Carmody RJ, Ruan Q, Palmer S, Hilliard B, Chen YH (2007) Negative regulation of toll-like receptor signaling by NF-kappaB p50 ubiquitination blockade. Science 317(5838):675-678.
10. Saccani S, Marazzi I, Beg AA, Natoli G (2004) Degradation of promoter-bound p65/RelA is essential for the prompt termination of the nuclear factor kappaB response. J Exp Med 200(1):107-113.
11. Bosisio D, et al. (2006) A hyper-dynamic equilibrium between promoter-bound and nucleoplasmic dimers controls NF-kappaB-dependent gene activity. EMBO J 25(4):798-810.
12. Geng H, Wittwer T, Dittrich-Breiholz O, Kracht M, Schmitz ML (2009) Phosphorylation of NF-kappaB p65 at Ser468 controls its COMMD1-dependent ubiquitination and target gene-speci fic proteasomal elimination. EMBO Rep 10(4):381-386.
13. Li H, et al. (2011) Regulation of NF-kappaB activity by competition between RelA acetylation and ubiquitination. Oncogene 31(5):611-623.
14. Komander D, Clague MJ, Urbé S (2009) Breaking the chains: Structure and function of the deubiquitinases. Nat Rev Mol Cell Biol 10(8):550-563.
15. Frappier L, Verrijzer CP (2011) Gene expression control by protein deubiquitinases. Curr Opin Genet Dev 21(2):207-213.
16. Everett RD, et al. (1997) A novel ubiquitin-specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein. EMBO J 16(7):1519-1530.
17. Daubeuf S, et al. (2009) HSV ICP0 recruits USP7 to modulate TLR-mediated innate response. Blood 113(14):3264-3275.
18. Li M, et al. (2002) Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization. Nature 416(6881):648-653.
19. Cummins JM, et al. (2004) Tumour suppression: Disruption of HAUSP gene stabilizes p53. Nature 428(6982):1 p following 486.
20. Song MS, et al. (2008) The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network. Nature 455(7214):813-817.
21. Maertens GN, El Messaoudi-Aubert S, Elderkin S, Hiom K, Peters G (2010) Ubiquitin-specific proteases 7 and 11 modulate Polycomb regulation of the INK4a tumour suppressor. EMBO J 29(15):2553-2565.
22. Epping MT, et al. (2011) TSPYL5 suppresses p53 levels and function by physical interaction with USP7. Nat Cell Biol 13(1):102-108.
23. Hong S, Kim SJ, Ka S, Choi I, Kang S (2002) USP7, a ubiquitin-specific protease, interacts with ataxin-1, the SCA1 gene product. Mol Cell Neurosci 20(2):298-306.
24. van der Horst A, et al. (2006) FOXO4 transcriptional activity is regulated by monoubiquitination and USP7/HAUSP. Nat Cell Biol 8(10):1064-1073.
25. Huang Z, et al. (2011) Deubiquitylase HAUSP stabilizes REST and promotes maintenance of neural progenitor cells. Nat Cell Biol 13(2):142-152.
26. Sowa ME, Bennett EJ, Gygi SP, Harper JW (2009) Defining the human deubiquitinating enzyme interaction landscape. Cell 138(2):389-403.
27. Colland F, et al. (2009) Small-molecule inhibitor of USP7/HAUSP ubiquitin protease stabilizes and activates p53 in cells. Mol Cancer Ther 8(8):2286-2295.
28. Lawrence T, Bebien M, Liu GY, Nizet V, Karin M (2005) IKKalpha limits macrophage NF-kappaB activation and contributes to the resolution of in fl ammation. Nature 434(7037):1138-1143.
29. Carmody RJ, Ruan Q, Liou HC, Chen YH (2007) Essential roles of c-Rel in TLR-induced IL-23 p19 gene expression in dendritic cells. J Immunol 178(1):186-191.
30. Hay RT, Nicholson J (1993) DNA binding alters the protease susceptibility of the p50 subunit of NF-kappa B. Nucleic Acids Res 21(19):4592-4598.
31. Matthews JR, et al. (1995) Conformational changes induced by DNA binding of NF-kappa B. Nucleic Acids Res 23(17):3393-3402.
32. Hager GL, McNally JG, Misteli T (2009) Transcription dynamics. Mol Cell 35(6):741-753.
33. Mathas S, Misteli T (2009) The dangers of transcription. Cell 139(6):1047-1049.
34. Kiely PA, et al. (2009) Phosphorylation of RACK1 on tyrosine 52 by c-Abl is required for insulin-like growth factor I-mediated regulation of focal adhesion kinase. J Biol Chem 284(30):20263-20274.